NDT Pharmaceuticals Inc. (NDTP)
OTCMKTS · Delayed Price · Currency is USD
0.5480
-0.0020 (-0.36%)
At close: Aug 4, 2026
NDT Pharmaceuticals Market Cap
NDT Pharmaceuticals has a market cap or net worth of $97.8 million as of August 6, 2026. Its market cap has increased by 902.00% in one year.
Market Cap
97.80M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.55
ChartMarket Cap Chart
Since October 21, 2011, NDT Pharmaceuticals's market cap has increased from 2.76M to 97.80M, an increase of 3,444.36%. That is a compound annual growth rate of 27.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 97.80M | -62.88% |
| Dec 31, 2025 | 263.50M | 3,007.18% |
| Dec 31, 2024 | 8.48M | -13.47% |
| Dec 28, 2023 | 9.80M | 1,785.32% |
| Dec 31, 2021 | 519.82K | -69.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 271.78M |
| CytoDyn | 257.74M |
| Glorywin Entertainment Group | 182.41M |
| Vaxart | 144.77M |
| HST Global | 99.00M |
| Cell Source | 60.13M |
| BioStem Technologies | 57.75M |
| Nuo Therapeutics | 48.41M |